NEW YORK (GenomeWeb News) – Cellectricon said today that the Automation Partnership will co-develop and manufacture Cellectricon’s DynaflowHT System, a high-throughput ion channel screening platform that the company plans to launch next year.
 
Cellectricon has been developing the Dynaflow HT platform, a cell-based microfluidics electrophysiology system, over the last three years in partnership with AstraZeneca.
 
Financial terms of the agreement with TAP were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.